Cite
HARVARD Citation
Giuliani, J. et al. (n.d.). P-221Regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer: The optimization of pharmacological costs. Annals of oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Giuliani, J. et al. (n.d.). P-221Regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer: The optimization of pharmacological costs. Annals of oncology. p. . [Online].